On February 1, 2023, the FTC announced a proposed $1.5 million settlement with GoodRx Holdings, based on alleged violations of the Federal Trade Commission Act (“FTC Act”) and Health Breach Notification Rule (“HBNR”) for using advertising technologies on its websites and mobile app that resulted in the unauthorized disclosure of consumers’ personal and health information to advertisers and other third parties. On the same day, the U.S. Department of Justice, acting on behalf of the FTC, filed a Complaint and Proposed Stipulated Order detailing the FTC’s allegations and the terms of the proposed settlement.
Blog Editors
Recent Updates
- Video: Federal Contractors Alert - DEI Restrictions Reinstated by Appeals Court - Employment Law This Week
- Video: Whistleblower Challenges and Employer Responses: One-on-One with Alex Barnard
- Video: New DOL Leadership, NLRB Quorum, EEOC Enforcement Priorities - Employment Law This Week
- DEI Executive Orders Are Back in Force with Court of Appeals Ruling
- Ohio Employers, Be Ready: The Paystub Protection Act Takes Effect Soon